Literature DB >> 16204411

TGF-beta1 induces IL-8 and MCP-1 through a connective tissue growth factor-independent pathway.

Weier Qi1, Xinming Chen, Tania S Polhill, Siska Sumual, Stephen Twigg, Richard E Gilbert, Carol A Pollock.   

Abstract

Transforming growth factor-beta(1) (TGF-beta(1)) functions as an important immunomodulatory cytokine in human kidney. Evidence suggests that connective tissue growth factor (CTGF) is an important downstream mediator of the profibrotic effects of TGF-beta(1). However, the role of CTGF in TGF-beta(1)-induced chemokine production remains unknown. This study was undertaken to determine whether CTGF is involved in mediating TGF-beta(1)-induced chemokine production in renal proximal tubular (HK-2) cells. Interleukin-8 (IL-8) and macrophage chemoattractant protein-1 (MCP-1) were measured. TGF-beta(1) induced an increase in IL-8 and MCP-1 (both P < 0.05) compared with control levels. CTGF was effectively silenced using small interference RNA (siRNA) in HK-2 cells. RT-PCR and real-time PCR confirmed a 94% reduction in CTGF mRNA. In the CTGF-silenced cells, TGF-beta(1)-stimulated IL-8 and MCP-1 secretion was not altered compared with control cells. Similarly, basal secretion of IL-8 and MCP-1 was not changed in CTGF-silenced cells. The direct effect of CTGF (20, 200, and 400 ng/ml) on IL-8 and MCP-1 was assessed at 24-, 48-, and 72-h time points and no stimulation was observed. Our studies further demonstrate that in the CTGF gene-silenced cells, CTGF partially mediates TGF-beta(1)-induced fibronectin and collagen IV secretion. These data suggest that TGF-beta(1) induced IL-8 and MCP-1 via CTGF-independent pathway. TGF-beta mediates both fibrosis and chemokine production in the proximal tubule of the kidney. However, CTGF plays a more specific role as a downstream mediator of TGF-beta(1)-induced fibrosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204411     DOI: 10.1152/ajprenal.00254.2005

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  21 in total

Review 1.  TGFβ biology in cancer progression and immunotherapy.

Authors:  Rik Derynck; Shannon J Turley; Rosemary J Akhurst
Journal:  Nat Rev Clin Oncol       Date:  2020-07-24       Impact factor: 66.675

2.  High glucose-induced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1.

Authors:  Weier Qi; Xinming Chen; Richard E Gilbert; Yuan Zhang; Mark Waltham; Maria Schache; Darren J Kelly; Carol A Pollock
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

3.  State of the art in intravesical therapy for lower urinary tract symptoms.

Authors:  Jonathan Kaufman; Vikas Tyagi; Michele Anthony; Michael B Chancellor; Pradeep Tyagi
Journal:  Rev Urol       Date:  2010

4.  Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases.

Authors:  Heloisa Reniers Vianna; Cristina Maria Bouissou M Soares; Katia Daniela Silveira; Gustavo Siqueira Elmiro; Philipe Melgaço Mendes; Marcelo de Sousa Tavares; Mauro Martins Teixeira; Débora Marques Miranda; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2012-11-18       Impact factor: 3.714

Review 5.  Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment.

Authors:  Federica Barutta; Graziella Bruno; Serena Grimaldi; Gabriella Gruden
Journal:  Endocrine       Date:  2014-10-02       Impact factor: 3.633

6.  Regulation of pro-inflammatory and pro-fibrotic factors by CCN2/CTGF in H9c2 cardiomyocytes.

Authors:  Xiaoyu Wang; Susan V McLennan; Terri J Allen; Stephen M Twigg
Journal:  J Cell Commun Signal       Date:  2010-02-02       Impact factor: 5.782

7.  Hypoxia in human trophoblasts stimulates the expression and secretion of connective tissue growth factor.

Authors:  Eli Rimon; Baosheng Chen; Anthony L Shanks; D Michael Nelson; Yoel Sadovsky
Journal:  Endocrinology       Date:  2008-02-21       Impact factor: 4.736

8.  Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection.

Authors:  A J Booth; K Csencsits-Smith; S C Wood; G Lu; K E Lipson; D K Bishop
Journal:  Am J Transplant       Date:  2009-09-25       Impact factor: 8.086

9.  PPAR-gamma agonists inhibit TGF-beta1-induced chemokine expression in human tubular epithelial cells.

Authors:  Wei-ming Wang; Hui-di Zhang; Yuan-meng Jin; Bing-bing Zhu; Nan Chen
Journal:  Acta Pharmacol Sin       Date:  2008-12-22       Impact factor: 6.150

Review 10.  How does TGF-β mediate tubulointerstitial fibrosis?

Authors:  Leslie Gewin; Roy Zent
Journal:  Semin Nephrol       Date:  2012-05       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.